224 related articles for article (PubMed ID: 21334976)
1. Prospects for the gene therapy of spinal muscular atrophy.
Passini MA; Cheng SH
Trends Mol Med; 2011 May; 17(5):259-65. PubMed ID: 21334976
[TBL] [Abstract][Full Text] [Related]
2. [Molecular genetic basis of proximal spinal muscular atrophy and experience in its pharmaceutical treatment].
Baranov VS; Kiselev AV; Vakharlovskiĭ VG; Zhelezniakova GIu; Komantsev VN; Malysheva OV; Glotov AS; Ivashchenko TE; Baranov AN
Genetika; 2008 Oct; 44(10):1325-37. PubMed ID: 19062530
[TBL] [Abstract][Full Text] [Related]
3. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice.
Dominguez E; Marais T; Chatauret N; Benkhelifa-Ziyyat S; Duque S; Ravassard P; Carcenac R; Astord S; Pereira de Moura A; Voit T; Barkats M
Hum Mol Genet; 2011 Feb; 20(4):681-93. PubMed ID: 21118896
[TBL] [Abstract][Full Text] [Related]
4. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease.
Monani UR
Neuron; 2005 Dec; 48(6):885-96. PubMed ID: 16364894
[TBL] [Abstract][Full Text] [Related]
5. Spinal muscular atrophy: state-of-the-art and therapeutic perspectives.
Wirth B
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):87-95. PubMed ID: 12215230
[TBL] [Abstract][Full Text] [Related]
6. Spinal muscular atrophy: recent advances and future prospects.
Nicole S; Diaz CC; Frugier T; Melki J
Muscle Nerve; 2002 Jul; 26(1):4-13. PubMed ID: 12115944
[TBL] [Abstract][Full Text] [Related]
7. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
[TBL] [Abstract][Full Text] [Related]
8. Is RNA manipulation a viable therapy for spinal muscular atrophy?
Horne C; Young PJ
J Neurol Sci; 2009 Dec; 287(1-2):27-31. PubMed ID: 19758605
[TBL] [Abstract][Full Text] [Related]
9. Spinal muscular atrophy: from gene to therapy.
Wirth B; Brichta L; Hahnen E
Semin Pediatr Neurol; 2006 Jun; 13(2):121-31. PubMed ID: 17027862
[TBL] [Abstract][Full Text] [Related]
10. CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.
Passini MA; Bu J; Roskelley EM; Richards AM; Sardi SP; O'Riordan CR; Klinger KW; Shihabuddin LS; Cheng SH
J Clin Invest; 2010 Apr; 120(4):1253-64. PubMed ID: 20234094
[TBL] [Abstract][Full Text] [Related]
11. Spinal muscular atrophy: from animal model to clinical trial.
Zanoteli E; Maximino JR; Conti Reed U; Chadi G
Funct Neurol; 2010; 25(2):73-9. PubMed ID: 20923604
[TBL] [Abstract][Full Text] [Related]
12. [Molecular basis of spinal muscular atrophy: th SMN gene].
Tizzano E; Baiget M
Neurologia; 2000 Nov; 15(9):393-400. PubMed ID: 11195146
[TBL] [Abstract][Full Text] [Related]
13. Correlation between severity and SMN protein level in spinal muscular atrophy.
Lefebvre S; Burlet P; Liu Q; Bertrandy S; Clermont O; Munnich A; Dreyfuss G; Melki J
Nat Genet; 1997 Jul; 16(3):265-9. PubMed ID: 9207792
[TBL] [Abstract][Full Text] [Related]
14. Correlation of survival motor neuron expression in leukocytes and spinal cord in spinal muscular atrophy.
Tsai LK; Yang CC; Ting CH; Su YN; Hwu WL; Li H
J Pediatr; 2009 Feb; 154(2):303-5. PubMed ID: 19150680
[TBL] [Abstract][Full Text] [Related]
15. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).
Wirth B
Hum Mutat; 2000; 15(3):228-37. PubMed ID: 10679938
[TBL] [Abstract][Full Text] [Related]
16. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy.
Liu H; Shafey D; Moores JN; Kothary R
J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194
[TBL] [Abstract][Full Text] [Related]
17. Spinal muscular atrophy: molecular genetics and diagnostics.
Ogino S; Wilson RB
Expert Rev Mol Diagn; 2004 Jan; 4(1):15-29. PubMed ID: 14711346
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy.
Al-Jumah M; Majumdar R; Al-Rajeh S; Awada A; Chaves-Carbello E; Salih M; Al-Shahwan S; Al-Subiey K; Al-Uthaim S
Saudi Med J; 2003 Oct; 24(10):1052-4. PubMed ID: 14578966
[TBL] [Abstract][Full Text] [Related]
19. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy.
DiMatteo D; Callahan S; Kmiec EB
Exp Cell Res; 2008 Feb; 314(4):878-86. PubMed ID: 18078930
[TBL] [Abstract][Full Text] [Related]
20. Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells.
Boda B; Mas C; Giudicelli C; Nepote V; Guimiot F; Levacher B; Zvara A; Santha M; LeGall I; Simonneau M
Eur J Hum Genet; 2004 Sep; 12(9):729-37. PubMed ID: 15162126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
